-Reuters
Liminal BioSciences Reports Q2 Financial Results 2023 Cash And Cash Equivalents Were $19.3M At June 30, 2023
Second Quarter Ended June 30th 2023 Financial Results
All figures presented in this section are in Canadian dollars.
Cash and cash equivalents were $19.3 million at June 30,